Beste apotheek van Nederland

Lane B Z, Ausmundson S J, Butler R S et al. Use of a visual
analog scale to assess pain of injection with intracavernous
injection therapy. Br J Sex Med 2005;2(3):428-431.
Laties A, Sharlip I. Ocular safety in patients using sildenafil
citrate therapy for erectile dysfunction. [Review] [81 refs]. Br J
Sex Med 2006;3(1):12-27.
Laties A M, Zrenner E. Viagra (sildenafil citrate) and
ophthalmology. Progress in Retinal & Eye Research
2002;21(5):485-506.
Laties A M, Fraunfelder F T, Flach A J et al. Ocular safety of
Viagra, (sildenafil citrate). Trans Am Ophthalmol Soc
1999;97(pp 115-128):-128.
Lawless C, Cree J. Oral medications in the management of
erectile dysfunction. [Review] [15 refs]. J Am Board Fam Pract
1998;11(4):307-314.
Lawless C, Force R W. Sildenafil for erectile dysfunction. J Fam
Pract 1998;47(2):97-98.
Lawrence I G, Price D E, Howlett T A et al. Correcting
impotence in the male dialysis patient: experience with
testosterone replacement and vacuum tumescence therapy. Am J
Kidney Dis 1998;31(2):313-319.
Le Bon O, Lion K, Verbanck P et al. Fluparoxan in male erectile
disorder: A case report. Yakubutsu Seishin Kodo 1995;9(1):67­
68.
Lea A P, Bryson H M, Balfour J A. Intracavernous alprostadil.
A review of its pharmacodynamic and pharmacokinetic
properties and therapeutic potential in erectile dysfunction.
[Review] [123 refs]. Drugs Aging 1996;8(1):56-74.
Lee J, Pommerville P, Brock G et al. Physician-rated patient
preference and patient- and partner-rated preference for tadalafil
or sildenafil citrate: results from the Canadian 'Treatment of
Erectile Dysfunction' observational study. BJU Int
2006;98(3):623-629.
Lee W R. The role of androgen deprivation therapy combined
with prostate brachytherapy. [Review] [31 refs]. Urology
2002;60(3:Suppl 1):Suppl-44.
Levine L A, Latchamsetty K C. Treatment of erectile
dysfunction in patients with Peyronie's disease using sildenafil
citrate. Int J Impot Res 2002;14(6):478-482.
Levitt E E, Mulcahy J J. The effect of intracavernosal injection
of papaverine hydrochloride on orgasm latency. Br J Sex Med
1995;21(1):39-42.
Lewis R L, Sadovsky R, Eardley I et al. The efficacy of tadalafil
in clinical populations. Br J Sex Med 2005;2(4):517-531.
Lewis R W. Intraurethral and topical agents. Med Actual
2000;36(2-3):113-119.
Li M K, Lim P H, Wong M Y et al. Transurethral
alprostadil for the treatment of erectile dysfunction:
results of a multicentre trial. Ann Acad Med
Singapore 2000;29(6):727-731.
Lim P H, Ng F C. Erectile dysfunction in Singapore
men: presentation, diagnosis, treatment and results.
Ann Acad Med Singapore 1992;21(2):248-253.
Lim P H C, Man K L, Foo C N et al. Clinical efficacy
and safety of sildenafil citrate (Viagra) in a multiracial
population in Singapore: A retrospective study
of 1520 patients. Int J Urol 2002;9(6):308-315.
Liu L C, Wu C C, Liu L H et al. Comparison of the
effects of papaverine versus prostaglandin E1 on
penile blood flow by color duplex sonography. Eur
Urol 1991;19(1):49-53.
Livi U, Faggian G, Sorbara C et al. Use of
prostaglandin E1 in the treatment of sexual impotence
after heart transplantation: initial clinical experience.
Journal of Heart & Lung Transplantation
1993;12(3):484-486.
Lombardo T, Giammusso B, Frontini V et al.
Thalassaemic men affected by erectile dysfunction
treated with transurethral alprostadil: case report. Hum
Reprod 2000;15(11):2375-2378.
Long R L, Sherman L S, Lombardi T J. A goaloriented,
cost-effective approach to the diagnosis and
treatment of 24 male erectile dysfunction. [Review]
[24 refs]. J Ky Med Assoc 1995;93(11):500-508.
Lottman P E, Hendriks J C, Vruggink P A et al. The
impact of marital satisfaction and psychological
counselling on the outcome of ICI-treatment in men
with ED. Int J Impot Res 1998;10(2):83-87.
Lowentritt B H, Scardino P T, Miles B J et al.
Sildenafil citrate after radical retropubic
prostatectomy. Br J Urol 1999;162(5):1614-1617.
Lowy M, Collins S, Bloch M et al. Quality of erection
questionnaire correlates: change in erection quality
with erectile function, hardness, and psychosocial
measures in men treated with sildenafil for erectile
dysfunction. Br J Sex Med 2007;4(1):83-92.
Lue T F. Impotence after radical pelvic surgery:
physiology and management. [Review] [56 refs]. Urol
Int 1991;46(3):259-265.
Lukkarinen O, Tonttila P, Hellstrom P et al. Nonprosthetic
surgery in the treatment of erectile
dysfunction. A retrospective study of 45 impotent
patients in the University of Oulu. Scandinavian
Journal of Urology & Nephrology 1998;32(1):42-46.
D-111